A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

Condition:   Early Breast Cancer
Interventions:   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Docetaxel;   Drug: Paclitaxel;   Drug: Pertuzumab IV;   Drug: FDC of Pertuzumab and Trastuzumab SC;   Drug: Trastuzumab IV;   Drug: Trastuzumab SC;   Procedure: Surgery;   Radiation: Post-operative Radiotherapy;   Drug: Hormone Therapy
Sponsor:   Hoffmann-La Roche
Not yet recruiting

https://ift.tt/2qoHDba